<DOC>
	<DOCNO>NCT02016274</DOCNO>
	<brief_summary>Metastatic esophageal squamous cell carcinoma poor prognosis majority patient resistant chemotherapy China . In investigator phase II clinical trial proceed , combination paclitaxel cisplatin show good tolerance efficacy esophageal squamous cell carcinoma . Radiotherapy indicate definitive treatment unresectable medically inoperable tumor ESCC patient . However , combination chemotherapy , also boundaries clinical target volume ( CTV ) internationally define . The investigator initiate prospective phase II clinical trial sequential paclitaxel/cisplatin radiotherapy 1st line treatment metastatic esophageal carcinoma observe efficacy safety combination .</brief_summary>
	<brief_title>Sequential Paclitaxel Plus Cisplatin Chemotherapy Radiotherapy 1st Line Treatment Esophageal Squamous Cell Cancer</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms , Squamous Cell</mesh_term>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>Having sign informed consent Age ≥18 year old Histologically confirm esophageal squamous carcinoma , metastatic disease primary tumor , prior palliative chemotherapy ; No prior radiotherapy except radiotherapy nontarget lesion study 3 month Sex limit Measurable disease accord RECIST criterion ( diameter lesion 10mm spiral CT MRI , 20mm common CT , date image le 15 day enrollment ) Karnofsky performance status ≥80 Life expectancy ≥ 3 month WBC &gt; 3,000/mm3 , absolute neutrophil count ≥1500/mm3 , platelet &gt; 100,000/mm3 , Hb &gt; 9g/dl ( within 14 day enrollment ) , ALT AST &lt; 2.5 time ULN ( ≤5 time ULN patient liver metastasis ) , Bilirubin level &lt; 1.0 time ULN , Serum AKP &lt; 2.5 time ULN , Serum creatinine &lt; 1.5 time ULN No sever complication , active gastrointestinal bleeding , perforation , jaundice , obstruction , noncancerous fever ＞ 38℃； Normal ECG heart function Fertile patient must use effective contraception Good compliance Previous treatment palliative chemotherapy Known hypersensitivity Paclitaxel , Cisplatin Only Brain bone metastasis No measurable lesion , eg . pleural fluid ascites Suffer severe heart disease disease important organ Chronic diarrhea renal dysfunction Pregnancy lactation period Other previous malignancy within 5 year , except nonmelanoma skin cancer Chronic diarrhea Mentally abnormal disable cognition , include CNS metastasis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
</DOC>